Pharmacist

PROBLEMS WITH CURRENT DOSING METHODS

  • Pets may need multiple medicines, multiple times each day
  • Oral dosage forms are not readily accepted by some pets
  • Requires supervision
  • Causes stress to the pets
  • Causes pet owner distress
  • Parent-Pet-Vet touch points not guaranteed
  • Supply chain integrity not assured
  • Lack of pet specific medicines
  • “Off-label” drug use is common
syringe

LIFESCIENT SOLUTION - IMPLANT

  • Eliminates hassles with periodic dosing and the need to remember schedule
  • No supervision required
  • By pass gastro intestinal (GI) tract and associated distress
  • Medicine immediately absorbed
  • Vet-Pet-Parent touch points & Pharmacovigilance ensured
  • Expeditious development and regulatory approval
  • Compliance and Quality of Care enhanced
  • Minimize “Off-label” drug use

WHAT ARE WE DOING TO HELP THE PET THERAPEUTICS INDUSTRY?

Lifescient is a development stage start up and is creating drug delivery platform to facilitate long-term, supervision-free treatment of certain chronic diseases that will also improve pet comfort, provide peace of mind for the pet parent, improve compliance, and eliminate frequent dosing.

We have a research program that is utilizing third party partners without building internal brick and mortar facilities thereby ensuring that all investment dollars are used to build intellectual property (IP). Lifescient will pursue a strategy to identify therapeutics approved for use in animals and human therapeutics used off-label in animals and reformulate them into an Implant dosage form.  Approved therapeutics have a history of use in humans and animals, well-characterized active pharmaceutical ingredients (API), defined and well-established process chemistry, a well characterized safety profile, and thus lower cost of development.

Lifescient has developed product prototypes and established proof of concept (POC) that will enable us to test in animals, file patents, apply for clinical trials in target species, and ultimately secure product approvals in multiple markets.

Subscribe

Sign up to receive updates, news, and more.